The COPD assessment test: What do we know so far? A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into gold stages

Chest

Volumn 149, Issue 2, 2016, Pages 413-425

  Karloh, Manuela ^a,b   Mayer, Anamaria Fleig ^b   Maurici, Rosemeri ^a   Pizzichini, Marcia M M ^a   Jones, Paul W ^c   Pizzichini, Emilio ^a,d  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b SANTA CATARINA STATE UNIVERSITY   (Brazil)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d Hospital Universitario   (Brazil)

Author keywords

Breathlessness; Chronic obstructive pulmonary disease; COPD; COPD assessment test; Health status

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST; CLINICAL ASSESSMENT TOOL; DEPRESSION; DISEASE EXACERBATION; FACTUAL DATABASE; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE CLASSIFICATION SYSTEM; HEALTH STATUS; HUMAN; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; MORTALITY; PATIENT CODING; PREDICTIVE VALUE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYMPTOM; SYSTEMATIC REVIEW; CLASSIFICATION; META ANALYSIS; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; REPRODUCIBILITY; RESPIRATORY TRACT EXAMINATION; SEVERITY OF ILLNESS INDEX; STANDARDS;

DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; HEALTH STATUS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RISK ADJUSTMENT; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84958078154     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.15-1752     Document Type: Article

References (33)

1. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875-1881.
2. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
3. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 suppl 1):32-37.
4. GOLD. Global Initiative for Chronic Obstructive Lung Disease. http://www.goldcopd.org/. Accessed July 15, 2015.
5. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321-1327.
6. Weldam SW, Schuurmans MJ, Liu R, Lammers JW. Evaluation of quality of life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud. 2013;50(5):688-707.
7. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10): 773-778.
8. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12-15.
9. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009;18(3):208-215.
10. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3): 648-654.
11. Jones PW. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. Eur Respir J. 1994;7(1):55-62.
12. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014; 44(4):873-884.
13. Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195-203.
14. Jones PW. COPD assessment test-rationale, development, validation and performance. COPD. 2013;10(2): 269-271.
15. Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339: b2535.
16. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8): 529-536.
17. Kelly JL, Bamsey O, Smith C, et al. Health status assessment in routine clinical practice: the Chronic Obstructive Pulmonary Disease Assessment Test score in outpatients. Respiration. 2012;84(3): 193-199.
18. Papaioannou M, Pitsiou G, Manika K, et al. COPD Assessment Test: a simple tool to evaluate disease severity and response to treatment. COPD. 2014;11(5): 489-495.
19. Lee YS, Park S, Oh YM, et al. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci. 2013;28(7):1048-1054.
20. Lee SD, Huang MS, Kang J, et al. The COPD Assessment Test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108(4):600-608.
21. Pothirat C, Chaiwong W, Limsukon A, et al. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score. Int J Chron Obstruct Pulmon Dis. 2015;10:277-282.
22. Raghavan N, Lam YM, Webb KA, et al. Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample. COPD. 2012;9(2):175-183.
23. Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148(1):159-168.
24. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43-50.
25. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647-654.
26. Kim S, Oh J, Kim YI, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med. 2013;13:35.
27. Pillai AP, Turner AM, Stockley RA. Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in alpha1-antitrypsin deficiency. Chest. 2013;144(4):1152-1162.
28. Casanova C, Marin JM, Martinez-Gonzalez C, et al. New GOLD classification: longitudinal data on group assignment. Respir Res. 2014;15:3.
29. Jones PW, Nadeau G, Small M, Adamek L. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med. 2014;108(1): 129-135.
30. Price DB, Baker CL, Zou KH, Higgins VS, Bailey JT, Pike JS. Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis. 2014;9: 551-561.
31. Rieger-Reyes C, Garcia-Tirado FJ, Rubio-Galan FJ, Marin-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new Global Initiative for Chronic Obstructive Lung Disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale. Arch Bronconeumol. 2014;50(4): 129-134.
32. Zogg S, Durr S, Miedinger D, Steveling EH, Maier S, Leuppi JD. Differences in classification of COPD patients into risk groups A-D: a cross-sectional study. BMC Res Notes. 2014;7(1):562.
33. Han J, Dai L, Zhong N, Young D. Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions. COPD. 2015;12(2): 115-125.